Walder Wyss advised Boehringer Ingelheim in the transaction. Boehringer Ingelheim announced the acquisition of privately-held T3 Pharmaceuticals AG, a clinical stage Swiss biotech company, for an...
Boehringer Ingelheim’s CHF450 Million Acquisition of T3 Pharmaceuticals AG
Nouscom’s €67.5 Million Oversuscribed Series C Financing Round
Walder Wyss advised the investors while VISCHER acted as legal advisor to Nouscom in the transaction. Nouscom, a clinical stage immuno-oncology company developing off-the-shelf and personalized...
CONVOTIS GmbH’s Acquisition of Acdalis AG
Walder Wyss advised CONVOTIS on all aspects of Swiss law on the transaction. CONVOTIS strengthens its position in Switzerland with the acquisition of acdalis AG, a...
proLogistik Holding GmbH’s Acquisition of Xelog AG
Walder Wyss advised the proLogistik group on the deal. Kellerhals Carrard advised DRS Investment GmbH. The private investment company DRS Investment GmbH has sold all shares...